Advanced Wound Care–In Your Practice learn more VHT-200 Vaporox has designed its next-generation (VHT-200) device and submitted a 510(k) to the FDA. Clearance is anticipated soon. Pending 510(K), not available for sale within the United States. Bioventus Acquires Minority Stake in Vaporox learn more Clinical Study demonstrates VHT heals 82%+ of chronic wounds read article Vaporox submits 510(k) to the FDA for its next-generation device VHT-200 I had a chronic DFU that was 6 years old and was preventing me from getting a lifesaving kidney and pancreatic transplant. After 9 weeks of treatment with VHT, my wound closed, and I received my transplant.” Ken Mitchell Sacramento, CA See video of Ken’s Story